Thursday, January 12, 2017

CORRECTED-UPDATE 1-CVS slashes price of Impax's EpiPen rival

Jan 12 (Reuters) - Drugstore chain CVS Health Corp

has cut the price of a generic version of Impax Laboratories

Inc's emergency allergy injection, a device similar to

Mylan NV's controversial EpiPen.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)